Related Experiment Video
Updated: Jun 2, 2025

Electrocardiogram Recordings in Anesthetized Mice using Lead II
Published on: June 20, 2020
Impact of prolonged QTc interval on mortality risk with hypertrophic cardiomyopathy
Shun Hasegawa1, Satoshi Higuchi1,2, Yuichiro Minami1
1Department of Cardiology Tokyo Women's Medical University Tokyo Japan.
Insights
In patients with hypertrophic cardiomyopathy (HCM), a prolonged corrected QT (QTc) interval is linked to an increased risk of HCM-related death. This finding highlights QTc prolongation as a significant predictor of adverse cardiac events in HCM patients.
Area of Science:
- Cardiology
- Electrophysiology
- Genetics
Background:
- The association between corrected QT (QTc) interval and life-threatening cardiac events in hypertrophic cardiomyopathy (HCM) patients is not well-established.
- This study aimed to clarify the relationship between QTc prolongation and HCM-related mortality.
Purpose of the Study:
- To investigate if a prolonged QTc interval is an independent predictor of HCM-related death.
- To determine the association between QTc prolongation and specific endpoints like sudden death or lethal arrhythmias in HCM.
Main Methods:
- A cohort of 445 HCM patients was analyzed.
- QTc interval was measured at baseline; prolongation was defined as >450 ms.
- HCM-related death included sudden death, lethal arrhythmias, heart failure, and stroke.
Main Results:
- 26.4% of patients had QTc prolongation at enrollment.
- Over 8.1 years median follow-up, 15.1% experienced HCM-related death.
- Prolonged QTc was independently associated with HCM-related death (aHR: 1.91) and sudden death/lethal arrhythmias (aHR: 2.01).
Conclusions:
- QTc prolongation is a significant independent risk factor for HCM-related death.
- This association extends to the combined endpoint of sudden death or potentially lethal arrhythmic events.
- QTc interval assessment may aid risk stratification in hypertrophic cardiomyopathy patients.
Background:
The association between corrected QT (QTc) interval and life-threatening cardiac events in patients with hypertrophic cardiomyopathy (HCM) remains unclear. This study sought to investigate whether the prolonged QTc was associated with HCM-related death in patients with HCM.
Methods:
We included 445 patients with HCM (mean age 51 ± 16 years, 67% men). The QTc interval was measured at the time of the initial evaluation and the patients were classified into those with and without QTc prolongation, which was defined as a QTc interval >450 ms. HCM-related death was defined as a combined endpoint of sudden death or potentially lethal arrhythmic events, heart failure-related death, and stroke-related death.
Results:
Prolonged QTc interval was found in 120 patients (26.4%) at the time of enrollment. Over a median (IQR) follow-up period of 8.1 (4.6-11.9) years, a total of 67 patients (15.1%) experienced HCM-related deaths including 57 (12.8%) with the endpoint of sudden death or potentially lethal arrhythmic events. In a multivariable analysis that included prolonged QTc interval and the risk factors for life-threatening events, prolonged QTc interval was independently associated with an HCM-related death (adjusted hazard ratio [HR]: 1.91; 95% confidence interval [CI]: 1.16-3.16; p = .011) and this trend also persisted for the combined endpoint of sudden death or potentially lethal arrhythmic events (adjusted HR: 2.01: 95% CI: 1.17-3.46; p = .012).
Conclusions:
In this cohort of patients with HCM, QTc prolongation may be associated with HCM-related death, including the endpoint of sudden death or potentially lethal arrhythmic events.
More Related Videos
14:39Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Related Concept Videos
Electrocardiogram
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
Mechanism of Cardiac Arrhythmias